======= NFE2L3 ======= == Gene Information == * **Official Symbol**: NFE2L3 * **Official Name**: nuclear factor, erythroid 2 like 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9603|9603]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y4A8|Q9Y4A8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NFE2L3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NFE2L3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604135|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Activates erythroid-specific, globin gene expression. |bZIP 1| |bZIP Maf| |transcription regulatory region sequence-specific DNA binding| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |transcription coactivator activity| |transcription by RNA polymerase II| |RNA polymerase II proximal promoter sequence-specific DNA binding| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |DNA-binding transcription factor activity| |negative regulation of transcription by RNA polymerase II| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |organic cyclic compound biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp287|HMS-I2 5μM R06 exp287]]|-2.03| |[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|1.81| |[[:results:exp111|R-DABN 8μM R03 exp111]]|1.97| |[[:results:exp93|DABN racemic mixture R03 exp93]]|2.1| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|2.13| |[[:results:exp64|Nocodazole 0.2μM R02 exp64]]|2.17| |[[:results:exp33|Rotenone 2μM R00 exp33]]|2.2| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|2.41| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|2.89| |[[:results:exp244|SB743921 0.001μM R05 exp244]]|3.33| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8183 * **Expression level (log2 read counts)**: 3.05 {{:chemogenomics:nalm6 dist.png?nolink |}}